30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Peter Neupert

Track

Insider profile

Currently holds positions in Adaptive Biotechnologies Corp and Labcorp Holdings Inc

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 32% 8.2% 15.1%
Success rate 91% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Lead Independent Director Adaptive Biotechnologies Corp Dec. 1, 2013 -
Lead Independent Director Labcorp Holdings Inc July 10, 2019 -
Independent Director Labcorp Holdings Inc Jan. 1, 2013 - July 10, 2019
Peter Neupert's trades of Fortrea Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-11 2025-08-11
B Purchase
32,920 +39.5%
217.65
US$4,626,947 		32,920 +39.5% 217.65 US$4,626,947
2025-08-11 2025-08-08
B Purchase
18,017 +20.6%
254.34
US$753,836 		18,017 +20.6% 254.34 US$753,836
2025-03-12 2025-03-10
S Sale
68,950 -39.0%
290.46
US$3,664,928 		68,950 -39.0% 290.46 US$3,664,928
2025-03-10 2025-03-10
PrS Proposed sale
10,000
7.05
US$70,450 		10,000 7.05 US$70,450
2023-08-23 2023-08-23
B Purchase
11,000 +100.0%
25.30
US$278,256 		11,000 +100.0% 25.30 US$278,256
2022-02-18 2022-02-16
B Purchase
600 +6.2%
264.57
US$158,742 		600 +6.2% 264.57 US$158,742
2022-02-18 2022-02-16
B Purchase
1,600 +19.9%
263.98
US$422,368 		1,600 +19.9% 263.98 US$422,368
2022-02-18 2022-02-16
B Purchase
1,300 +19.2%
262.85
US$341,705 		1,300 +19.2% 262.85 US$341,705